Status:
COMPLETED
Use of Chamomilla Recutita in Phlebitis
Lead Sponsor:
University of Sao Paulo
Conditions:
Phlebitis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To verify the efficacy of topical applications of Chamomilla recutita infusion for phlebitis treatment, before dose response curve study and pilot study.
Detailed Description
The hypothesis adopted was that patients with phlebitis due to peripheral intravenous infusion in anti-neoplasm chemotherapy, treated with a compress of Chamomilla recutita infusion for 20 minutes thr...
Eligibility Criteria
Inclusion
- Subjects with cancer who had infusion phlebitis during the administration of intravenous chemotherapy peripheral under hospitalization.
Exclusion
- Report made by the subject of study, prior hypersensitivity reaction or presentation during the research, adverse reaction to chamomile or any plant of the family Asteraceae ou Compositae: margarida (Aster tripolium), crisântemo (Chrysanthemum leucanthemum), artemísia or isopo santo (Artemísia vulgaris), carpineira or ambrósia americana (Ambrosia artemisiifolia) and senécio (Senecio jacobaea L.);
- Prescription during the process of data collection, some kind of anti-inflammatory with systemic or topical activity where it was located phlebitis, and, upon the occurrence of bacterial phlebitis, had been prescribed topical or systemic antibiotic therapy;
- Refusal of the subject to participate in the study, regardless of the time.
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT00989599
Start Date
September 1 2004
End Date
September 1 2008
Last Update
October 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Base do Distrito Federal
Brasília, Brasília/DF, Brazil